DaVita
DVA
#1966
Rank
NZ$17.21 B
Marketcap
NZ$257.54
Share price
-0.28%
Change (1 day)
-3.06%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.32

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.41. In 2024 the company made an earnings per share (EPS) of NZ$18.98 an increase over its 2023 EPS that were of NZ$13.09.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.32-8.71%
2024NZ$18.9844.94%
2023NZ$13.0927.26%
2022NZ$10.29-35.56%
2021NZ$15.9744.1%
2020NZ$11.0819.7%
2019NZ$9.26540.48%
2018NZ$1.45-76.07%
2017NZ$6.04-19.31%
2016NZ$7.48242.52%
2015NZ$2.18-62.87%
2014NZ$5.8813.43%
2013NZ$5.198.45%
2012NZ$4.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$40.38 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$18.12 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$25.29 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.27-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA